nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—ulcerative colitis	0.377	0.563	CbGaD
Pranlukast—NFKB1—ulcerative colitis	0.224	0.335	CbGaD
Pranlukast—TNF—ulcerative colitis	0.0687	0.103	CbGaD
Pranlukast—ABCC2—Sulfasalazine—ulcerative colitis	0.0349	0.211	CbGbCtD
Pranlukast—CYP3A4—Budesonide—ulcerative colitis	0.0201	0.122	CbGbCtD
Pranlukast—ABCC2—Dexamethasone—ulcerative colitis	0.0174	0.105	CbGbCtD
Pranlukast—CYP2C9—Nicotine—ulcerative colitis	0.0151	0.0912	CbGbCtD
Pranlukast—CYP2C9—Cholecalciferol—ulcerative colitis	0.0135	0.0818	CbGbCtD
Pranlukast—CYP3A4—Methylprednisolone—ulcerative colitis	0.00899	0.0544	CbGbCtD
Pranlukast—CYP3A4—Nicotine—ulcerative colitis	0.00876	0.053	CbGbCtD
Pranlukast—CYP3A4—Cholecalciferol—ulcerative colitis	0.00786	0.0476	CbGbCtD
Pranlukast—CYP3A4—Triamcinolone—ulcerative colitis	0.00682	0.0412	CbGbCtD
Pranlukast—ABCC2—bile duct—ulcerative colitis	0.00629	0.143	CbGeAlD
Pranlukast—CYP2C9—Dexamethasone—ulcerative colitis	0.00585	0.0354	CbGbCtD
Pranlukast—CYP3A4—Betamethasone—ulcerative colitis	0.00585	0.0354	CbGbCtD
Pranlukast—CYP3A4—Prednisolone—ulcerative colitis	0.00577	0.0349	CbGbCtD
Pranlukast—CYP3A4—Hydrocortisone—ulcerative colitis	0.00547	0.0331	CbGbCtD
Pranlukast—CYP3A4—Prednisone—ulcerative colitis	0.00545	0.033	CbGbCtD
Pranlukast—ABCC2—bile—ulcerative colitis	0.00483	0.11	CbGeAlD
Pranlukast—IL5—epithelium—ulcerative colitis	0.00403	0.0915	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—ulcerative colitis	0.00342	0.0776	CbGeAlD
Pranlukast—CYP3A4—Dexamethasone—ulcerative colitis	0.0034	0.0206	CbGbCtD
Pranlukast—RNASE3—digestive system—ulcerative colitis	0.00338	0.0767	CbGeAlD
Pranlukast—IL5—lymphoid tissue—ulcerative colitis	0.0031	0.0705	CbGeAlD
Pranlukast—MUC2—epithelium—ulcerative colitis	0.0031	0.0704	CbGeAlD
Pranlukast—IL5—digestive system—ulcerative colitis	0.00307	0.0696	CbGeAlD
Pranlukast—MUC2—digestive system—ulcerative colitis	0.00236	0.0535	CbGeAlD
Pranlukast—MUC2—liver—ulcerative colitis	0.00176	0.0399	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—ulcerative colitis	0.00167	0.038	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—ulcerative colitis	0.00136	0.0309	CbGeAlD
Pranlukast—NFKB1—digestive system—ulcerative colitis	0.00134	0.0305	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—ulcerative colitis	0.00134	0.0304	CbGeAlD
Pranlukast—NFKB1—liver—ulcerative colitis	0.001	0.0227	CbGeAlD
Pranlukast—Candesartan—PTGS1—ulcerative colitis	0.000786	0.673	CrCbGaD
Pranlukast—ABCC2—digestive system—ulcerative colitis	0.000528	0.012	CbGeAlD
Pranlukast—ABCC2—liver—ulcerative colitis	0.000393	0.00893	CbGeAlD
Pranlukast—Candesartan—ABCB1—ulcerative colitis	0.000382	0.327	CrCbGaD
Pranlukast—CYP2C9—digestive system—ulcerative colitis	0.000352	0.00798	CbGeAlD
Pranlukast—CYP3A4—digestive system—ulcerative colitis	0.000268	0.00609	CbGeAlD
Pranlukast—CYP2C9—liver—ulcerative colitis	0.000262	0.00595	CbGeAlD
Pranlukast—CYP3A4—liver—ulcerative colitis	0.0002	0.00454	CbGeAlD
Pranlukast—IL5—Signaling Pathways—GHRL—ulcerative colitis	2.62e-05	0.000218	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GNA12—ulcerative colitis	2.62e-05	0.000218	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—ulcerative colitis	2.6e-05	0.000217	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—ulcerative colitis	2.59e-05	0.000216	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RIPK2—ulcerative colitis	2.59e-05	0.000216	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—ulcerative colitis	2.58e-05	0.000215	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	2.57e-05	0.000214	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CTLA4—ulcerative colitis	2.55e-05	0.000213	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—ulcerative colitis	2.54e-05	0.000211	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CALM3—ulcerative colitis	2.54e-05	0.000211	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.53e-05	0.00021	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RIPK2—ulcerative colitis	2.5e-05	0.000208	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	2.5e-05	0.000208	CbGpPWpGaD
Pranlukast—IL5—Immune System—CRP—ulcerative colitis	2.49e-05	0.000207	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—ulcerative colitis	2.48e-05	0.000207	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCR2—ulcerative colitis	2.48e-05	0.000207	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL8—ulcerative colitis	2.48e-05	0.000206	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.47e-05	0.000206	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—ulcerative colitis	2.47e-05	0.000206	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.46e-05	0.000205	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—ulcerative colitis	2.46e-05	0.000205	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	2.45e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NOD2—ulcerative colitis	2.44e-05	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD79A—ulcerative colitis	2.43e-05	0.000203	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD14—ulcerative colitis	2.43e-05	0.000202	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—ulcerative colitis	2.43e-05	0.000202	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—ulcerative colitis	2.41e-05	0.0002	CbGpPWpGaD
Pranlukast—IL5—Immune System—TLR4—ulcerative colitis	2.39e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-DRB1—ulcerative colitis	2.39e-05	0.000199	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	2.35e-05	0.000196	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—ulcerative colitis	2.34e-05	0.000195	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR6—ulcerative colitis	2.33e-05	0.000194	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB1—ulcerative colitis	2.3e-05	0.000192	CbGpPWpGaD
Pranlukast—IL5—Immune System—ICAM1—ulcerative colitis	2.29e-05	0.000191	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TGFB1—ulcerative colitis	2.28e-05	0.00019	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—STAT3—ulcerative colitis	2.28e-05	0.00019	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB1—ulcerative colitis	2.26e-05	0.000188	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—VCAM1—ulcerative colitis	2.25e-05	0.000188	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGAL—ulcerative colitis	2.25e-05	0.000187	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—STAT3—ulcerative colitis	2.25e-05	0.000187	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DQA1—ulcerative colitis	2.25e-05	0.000187	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—RELA—ulcerative colitis	2.24e-05	0.000187	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—ulcerative colitis	2.24e-05	0.000187	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADCY5—ulcerative colitis	2.24e-05	0.000186	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—ulcerative colitis	2.22e-05	0.000185	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAML2—ulcerative colitis	2.21e-05	0.000184	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—JAK2—ulcerative colitis	2.21e-05	0.000184	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—ulcerative colitis	2.2e-05	0.000183	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	2.19e-05	0.000183	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SEL1L—ulcerative colitis	2.18e-05	0.000182	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—ulcerative colitis	2.18e-05	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—JAK2—ulcerative colitis	2.17e-05	0.000181	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADRB2—ulcerative colitis	2.17e-05	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IFNG—ulcerative colitis	2.17e-05	0.00018	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.15e-05	0.000179	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—JAK2—ulcerative colitis	2.14e-05	0.000178	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—RELA—ulcerative colitis	2.14e-05	0.000178	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRF5—ulcerative colitis	2.14e-05	0.000178	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—TGFB1—ulcerative colitis	2.11e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CXCL8—ulcerative colitis	2.11e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—ulcerative colitis	2.11e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—RELA—ulcerative colitis	2.1e-05	0.000175	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—ulcerative colitis	2.1e-05	0.000175	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—NFKB1—ulcerative colitis	2.07e-05	0.000172	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTGER4—ulcerative colitis	2.05e-05	0.000171	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CCR6—ulcerative colitis	2.04e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IRF8—ulcerative colitis	2.04e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.04e-05	0.00017	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	2.03e-05	0.000169	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDH1—ulcerative colitis	2.02e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ADCY5—ulcerative colitis	1.99e-05	0.000165	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	1.98e-05	0.000165	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—ulcerative colitis	1.96e-05	0.000163	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL8—ulcerative colitis	1.95e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FCGR2A—ulcerative colitis	1.95e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—JAK2—ulcerative colitis	1.94e-05	0.000162	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—ulcerative colitis	1.93e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—ulcerative colitis	1.93e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL2—ulcerative colitis	1.93e-05	0.00016	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.9e-05	0.000159	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—ulcerative colitis	1.9e-05	0.000158	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—ulcerative colitis	1.88e-05	0.000157	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GHRL—ulcerative colitis	1.88e-05	0.000157	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTPN2—ulcerative colitis	1.87e-05	0.000156	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.87e-05	0.000155	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—IL2—ulcerative colitis	1.87e-05	0.000155	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—ulcerative colitis	1.86e-05	0.000155	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADCY5—ulcerative colitis	1.84e-05	0.000153	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CALM3—ulcerative colitis	1.82e-05	0.000152	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—ulcerative colitis	1.82e-05	0.000151	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.81e-05	0.000151	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—ulcerative colitis	1.8e-05	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR1—ulcerative colitis	1.79e-05	0.000149	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RIPK2—ulcerative colitis	1.79e-05	0.000149	CbGpPWpGaD
Pranlukast—IL5—Immune System—JAK2—ulcerative colitis	1.77e-05	0.000148	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL8—ulcerative colitis	1.77e-05	0.000148	CbGpPWpGaD
Pranlukast—IL5—Immune System—IFNG—ulcerative colitis	1.74e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—ulcerative colitis	1.74e-05	0.000145	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—ulcerative colitis	1.72e-05	0.000143	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—ulcerative colitis	1.72e-05	0.000143	CbGpPWpGaD
Pranlukast—IL5—Immune System—RELA—ulcerative colitis	1.72e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—ulcerative colitis	1.72e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—STAT3—ulcerative colitis	1.7e-05	0.000141	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL2—ulcerative colitis	1.69e-05	0.000141	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—ulcerative colitis	1.68e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.68e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PPARG—ulcerative colitis	1.68e-05	0.00014	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR4—ulcerative colitis	1.67e-05	0.000139	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	1.65e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	1.63e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—STAT3—ulcerative colitis	1.62e-05	0.000135	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DRB1—ulcerative colitis	1.6e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CALM3—ulcerative colitis	1.59e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—STAT3—ulcerative colitis	1.59e-05	0.000133	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—ulcerative colitis	1.59e-05	0.000133	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL20—ulcerative colitis	1.58e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RIPK2—ulcerative colitis	1.57e-05	0.000131	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—ulcerative colitis	1.57e-05	0.000131	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRB2—ulcerative colitis	1.56e-05	0.00013	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.55e-05	0.000129	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—ulcerative colitis	1.55e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTLA4—ulcerative colitis	1.55e-05	0.000129	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—ulcerative colitis	1.55e-05	0.000129	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—JAK2—ulcerative colitis	1.54e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ICAM1—ulcerative colitis	1.53e-05	0.000128	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—ulcerative colitis	1.51e-05	0.000126	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	1.51e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNA12—ulcerative colitis	1.48e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD79A—ulcerative colitis	1.48e-05	0.000123	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.45e-05	0.000121	CbGpPWpGaD
Pranlukast—IL5—Immune System—NFKB1—ulcerative colitis	1.45e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NOD2—ulcerative colitis	1.42e-05	0.000119	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—ulcerative colitis	1.42e-05	0.000118	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD14—ulcerative colitis	1.42e-05	0.000118	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR2—ulcerative colitis	1.4e-05	0.000117	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—JAK2—ulcerative colitis	1.4e-05	0.000117	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.4e-05	0.000117	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—JAK2—ulcerative colitis	1.39e-05	0.000116	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—ulcerative colitis	1.38e-05	0.000115	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—VCAM1—ulcerative colitis	1.37e-05	0.000114	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DQA1—ulcerative colitis	1.36e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RELA—ulcerative colitis	1.36e-05	0.000113	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.36e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDH1—ulcerative colitis	1.36e-05	0.000113	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—ulcerative colitis	1.34e-05	0.000112	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADCY5—ulcerative colitis	1.32e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR6—ulcerative colitis	1.32e-05	0.00011	CbGpPWpGaD
Pranlukast—IL5—Immune System—STAT3—ulcerative colitis	1.3e-05	0.000108	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—ulcerative colitis	1.3e-05	0.000108	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.28e-05	0.000107	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PPARG—ulcerative colitis	1.28e-05	0.000106	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—ulcerative colitis	1.27e-05	0.000106	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAML2—ulcerative colitis	1.25e-05	0.000104	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—JAK2—ulcerative colitis	1.24e-05	0.000103	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—ulcerative colitis	1.22e-05	0.000101	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RELA—ulcerative colitis	1.2e-05	9.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—ulcerative colitis	1.19e-05	9.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—ulcerative colitis	1.17e-05	9.78e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTGER4—ulcerative colitis	1.16e-05	9.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—ulcerative colitis	1.16e-05	9.64e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ADCY5—ulcerative colitis	1.16e-05	9.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RELA—ulcerative colitis	1.15e-05	9.59e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—JAK2—ulcerative colitis	1.15e-05	9.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—ulcerative colitis	1.13e-05	9.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—ulcerative colitis	1.13e-05	9.39e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—ulcerative colitis	1.11e-05	9.27e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RELA—ulcerative colitis	1.11e-05	9.25e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—JAK2—ulcerative colitis	1.07e-05	8.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GHRL—ulcerative colitis	1.06e-05	8.86e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—ulcerative colitis	1.05e-05	8.72e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RELA—ulcerative colitis	1.03e-05	8.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CALM3—ulcerative colitis	1.03e-05	8.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—STAT3—ulcerative colitis	1.03e-05	8.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CHP1—ulcerative colitis	1.02e-05	8.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RIPK2—ulcerative colitis	1.02e-05	8.46e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—ulcerative colitis	1.01e-05	8.43e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—ulcerative colitis	1e-05	8.33e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—ulcerative colitis	9.96e-06	8.29e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR4—ulcerative colitis	9.7e-06	8.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DRB1—ulcerative colitis	9.69e-06	8.07e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.59e-06	7.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—ulcerative colitis	9.54e-06	7.94e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—ulcerative colitis	9.47e-06	7.89e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NFKB1—ulcerative colitis	9.37e-06	7.8e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ICAM1—ulcerative colitis	9.3e-06	7.75e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—ulcerative colitis	9.1e-06	7.58e-05	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ALB—ulcerative colitis	9.1e-06	7.58e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—ulcerative colitis	8.91e-06	7.42e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DLD—ulcerative colitis	8.84e-06	7.36e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—ulcerative colitis	8.82e-06	7.34e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB2—ulcerative colitis	8.81e-06	7.34e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NFKB1—ulcerative colitis	8.72e-06	7.27e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—STAT3—ulcerative colitis	8.42e-06	7.01e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—JAK2—ulcerative colitis	8.24e-06	6.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDH1—ulcerative colitis	8.23e-06	6.85e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RELA—ulcerative colitis	7.98e-06	6.64e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—STAT3—ulcerative colitis	7.84e-06	6.53e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—ulcerative colitis	7.81e-06	6.5e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—ulcerative colitis	7.52e-06	6.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADCY5—ulcerative colitis	7.48e-06	6.23e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—ulcerative colitis	7.27e-06	6.05e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—JAK2—ulcerative colitis	7.21e-06	6.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—ulcerative colitis	7.19e-06	5.99e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—ulcerative colitis	7.18e-06	5.98e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—ulcerative colitis	7.15e-06	5.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNG—ulcerative colitis	7.08e-06	5.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RELA—ulcerative colitis	6.98e-06	5.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—ulcerative colitis	6.84e-06	5.69e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—ulcerative colitis	6.8e-06	5.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CHP1—ulcerative colitis	6.75e-06	5.62e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NFKB1—ulcerative colitis	6.73e-06	5.6e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—ulcerative colitis	6.43e-06	5.35e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—ulcerative colitis	6.35e-06	5.29e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—ulcerative colitis	6.31e-06	5.26e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—ulcerative colitis	6.29e-06	5.24e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—STAT3—ulcerative colitis	6.04e-06	5.03e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—ulcerative colitis	5.88e-06	4.9e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DLD—ulcerative colitis	5.83e-06	4.85e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—ulcerative colitis	5.6e-06	4.67e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—ulcerative colitis	5.48e-06	4.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—STAT3—ulcerative colitis	5.29e-06	4.41e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.67e-06	3.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—JAK2—ulcerative colitis	4.66e-06	3.88e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—ulcerative colitis	4.61e-06	3.84e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RELA—ulcerative colitis	4.52e-06	3.76e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS1—ulcerative colitis	4.27e-06	3.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—ulcerative colitis	4.26e-06	3.54e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—ulcerative colitis	4.22e-06	3.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.2e-06	3.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—ulcerative colitis	4.07e-06	3.39e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—ulcerative colitis	3.85e-06	3.21e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CALM3—ulcerative colitis	3.85e-06	3.2e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—ulcerative colitis	3.7e-06	3.08e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.68e-06	3.06e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT3—ulcerative colitis	3.42e-06	2.85e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—ulcerative colitis	3.17e-06	2.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—ulcerative colitis	2.99e-06	2.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS1—ulcerative colitis	2.82e-06	2.35e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADCY5—ulcerative colitis	2.79e-06	2.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—ulcerative colitis	2.61e-06	2.17e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CALM3—ulcerative colitis	2.54e-06	2.11e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—ulcerative colitis	2.39e-06	1.99e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.08e-06	1.73e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.97e-06	1.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—ulcerative colitis	1.87e-06	1.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.84e-06	1.53e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—ulcerative colitis	1.64e-06	1.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.37e-06	1.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—ulcerative colitis	1.23e-06	1.03e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.08e-06	8.99e-06	CbGpPWpGaD
